Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB nonsmall cell lung carcinoma-Reference-Cited by-同舟云学术

Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB nonsmall cell lung carcinoma

Published:2003-05-22 Issue:1 Volume:98 Page:128-134
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Cappuzzo Federico,Selvaggi Giovanni,Gregorc Vanesa,Mazzoni Francesca,Betti Maura,Rita Migliorino Maria,Novello Silvia,Maestri Antonio,De Marinis Filippo,Darwish Samir,De Angelis Verena,Nelli Fabrizio,Bartolini Stefania,Scagliotti Giorgio V.,Tonato Maurizio,Crinò Lucio

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference28 articles.

1. Multimodality therapy for non-small cell lung cancer;Lilenbaum;Oncology.,1994

2. Clinical practice guidelines for the treatment of unresectable non-small cell lung cancer: adopted on May 16, 1997 by the American Society of Clinical Oncology;American Society of Clinical Oncology;J Clin Oncol.,1997

3. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials;Non-Small Cell Lung Cancer Collaborative Group;BMJ.,1995

4. Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in Stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis;Marino;Cancer.,1995

5. Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis;Pritchard;Ann Intern Med.,1996

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updated review of perioperative treatment for non-small-cell lung cancer in the new era of immune checkpoint inhibitors: past, present, and future;Japanese Journal of Clinical Oncology;2024-08-20

2. Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi Process;Current Oncology;2023-12-06

3. Dose-dense Paclitaxel and Carboplatin as Neoadjuvant Chemotherapy for Stage IIB/IIIA Non-small Cell Lung Cancer – A Phase II trial;Clinical Oncology;2021-12

4. Identification of Resectable N2 in NSCLC: A Single Center Experience and Review of the SEER Database;Frontiers in Oncology;2021-04-26

5. Before or After: Evolving Neoadjuvant Approaches to Locally Advanced Non-Small Cell Lung Cancer;Frontiers in Oncology;2018-01-23